OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $488,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 935 shares of the medical equipment provider’s stock, valued at approximately $488,000.

A number of other hedge funds have also bought and sold shares of the company. Atala Financial Inc bought a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth $26,000. Finally, BankPlus Trust Department acquired a new position in Intuitive Surgical in the fourth quarter worth $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG opened at $563.95 on Wednesday. The stock’s 50 day moving average price is $501.31 and its 200 day moving average price is $535.58. The stock has a market cap of $202.13 billion, a P/E ratio of 87.98, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $379.67 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now owns 6,371 shares of the company’s stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,636 shares of company stock worth $16,829,815 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.